US Opening Bell | Stocks open lower; Antelope Enterprise soars 151% & Liquidia 39%; Chip stocks skid

US Opening Bell10-14

Market

October 14, U.S. stocks opened broadly lower as a hotter-than-expected inflation print and renewed Middle East cease-fire hopes pressured risk sentiment. The Dow Jones eased 0.1%, the S&P 500 slipped 0.4% and the tech-heavy Nasdaq Composite fell 0.7%, while Treasury yields inched higher and crude prices retreated.

Antelope Enterprise Holdings Limited rockets 150.8% after unveiling a strategic pivot into smart-roofing materials for U.S. data-center projects. Liquidia Technologies Inc jumps 39.4% on FDA approval of its inhaled pulmonary-hypertension therapy. Jianzhi Education Technology Group Company Ltd climbs 20.9% after announcing a large AI curriculum deal with a Florida school district. Direxion Daily Semiconductors Bear 3x Shares gains 6.3% as chip shares tumble. On the downside, CoreWeave, Inc. falls 9.7% following reports of slowing cloud-GPU demand, Bank of America slides 6.7% after a profit miss, Taiwan Semiconductor Manufacturing slips 1.3% on fresh U.S. export curbs, NVIDIA loses 1.4%, and Tesla Motors retreats 1.6% after new price cuts reignite margin worries.

Semiconductor weakness deepens with Applied Optoelectronics down 2.8%, Advanced Micro Devices off 2.8%, Marvell Technology lower by 2.6%, Intel down 2.2% and Micron Technology 1.7% softer. Broadcom sheds 1.6% as suppliers flag inventory build-ups. SPDR Gold ETF declines 1.5% as rising real yields dent haven demand, while Direxion Daily Semiconductors Bull 3x Shares skids 6.1%, underscoring the sector’s risk-off tone.

News

Liquidia Technologies Inc wins FDA approval for Yutrepia. The regulator cleared the company’s inhaled therapy for pulmonary arterial hypertension, opening a path to commercial launch. Management forecast blockbuster potential, sending the stock up 39%.

Bank of America misses Q3 earnings estimates. Higher credit-loss provisions and weaker trading revenue cut into profits. Shares fell 6.7% as analysts trimmed full-year forecasts.

NVIDIA hit by expanded U.S. chip export restrictions. The Commerce Department tightened rules on AI accelerator sales to China, raising revenue uncertainty. The stock slipped 1.4% at the open.

Tesla Motors cuts Model Y prices again. The EV leader trimmed U.S. prices by up to $2,000 to spur demand amid rising competition, stoking margin concerns and pushing shares down 1.6%.

U.S. core CPI tops estimates. Core consumer prices rose 0.3% month-over-month, above the 0.2% consensus. Sticky services inflation reignited fears of further Fed tightening.

Federal Reserve minutes signal data-dependent hawkish tilt. Policymakers indicated readiness to raise rates if inflation persists, lifting the 10-year Treasury yield to a new cycle high near 4.95%.

Antelope Enterprise Holdings Limited pivots to U.S. smart-roofing market. The ceramic-tile maker announced a joint venture to supply solar roof solutions, triggering a 151% surge in thinly traded shares.

ASML Holding NV warns of slower China orders. The Dutch chip-equipment giant cited U.S. export controls as a headwind, and its U.S.-listed shares eased 0.9%, pressuring broader semiconductor sentiment.

WTI crude slips 2% on Middle East cease-fire talks. Easing geopolitical risk reduced safe-haven oil buying, dragging energy explorers lower in early trade.

Meta Platforms, Inc. faces EU scrutiny over ad-free subscription plan. Regulators questioned the legality of its pay-or-approve-ads model, adding to regulatory overhang; U.S. shares edged 0.9% lower.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment